Characterized and predictable rabbit uveitis model for antiinflammatory drug screening.

Area of Science:

• Ophthalmology
• Immunology
• Pharmacology

Background:

• Developing effective anti-inflammatory ophthalmic drugs requires reliable preclinical screening models.
• Existing methods for evaluating ocular inflammation can be slow, less reproducible, or require more animal subjects.

Purpose of the Study:

• To develop and validate a novel, efficient, and reproducible animal model for screening anti-inflammatory ophthalmic drugs.
• To establish a method that minimizes animal usage while maintaining accuracy and precision.

Main Methods:

• Rabbits were sensitized to bovine serum proteins and challenged intravitreally to induce immunologic uveitis.
• Animals were grouped based on iris inflammation scores (slit lamp examination) 24 hours post-challenge.
• Topical ocular treatments were administered for four days, with daily slit lamp evaluations of iris inflammation.

Main Results:

• The developed model demonstrated a statistically narrower frequency distribution of iris ratings compared to other published methods.
• The model proved to be faster than methods relying on blood antibody titers for animal stratification.
• The inflammatory response was confirmed to be primarily immunologic in nature.

Conclusions:

• This rabbit model provides a simple, rapid, and reproducible platform for screening anti-inflammatory ophthalmic drugs.
• The method's efficiency in animal grouping and speed offers advantages over existing techniques.
• The model's reliance on direct inflammation assessment enhances its utility in preclinical drug evaluation.